Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLZR:a potential 10 bagger? -- Ignore unavailable to you. Want to Upgrade?

To: M. Frank Greiffenstein who wrote (142)	5/20/1999 2:32:00 PM
From: Bob Davis	Read Replies (1) \| Respond to of 315

Doc... Very old news...and not very significant. Candela Corporation (NASDAQ:CLZR) price declined sharply earlier this morning, after a company called Clickmed put out a press release announcing "a Low Cost Generic Cryogen Replacement for Candela (CLZR) Lasers". This replacement cartridge has been sold by this outfit for some time now, and they have put out similar press releases in the past. In fact, I cited this development as an indicator of CLZR's market strength in my April 19th Analysis Update. In this update I also noted that "These cartridges are a very small percentage (1-2%) of CLZR's total sales." In response to some questions about the usage of these cartridges, I talked by phone with CLZR management and learned that each of these cartridges contains enough cryogen for about 4,000 individual pulses. Simple procedures normally use about 20 pulses, and an entire set of legs might use between 800 and 1000 pulses. As a result, one cartridge can be used to perform as many as 200 individual simple procedures, and 4 or more large procedures. Although Clickmed has been offering these cartridges for some time now, CLZR does not feel that this alternate supplier is having much of an impact on the Company's sales of these cartridges. Net-net, this is not a major event... Bob Davis The Napeague Letter napeague.com